A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2002
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254132A1 Food product and process
11/06/2002	EP1254130A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/06/2002	EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP1253919A1 Method and compositions for treating an inflammatory disease
11/06/2002	EP1253904A2 Extracts from residues left in the production of wine
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	EP1107731B1 Synthetic tear fluid
11/06/2002	EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002	EP1000038B1 Novel pyrimidin derivatives
11/06/2002	EP0951287B1 Oral composition comprising 5-aminosalicyclic acid
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002	EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002	CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378543A Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002	CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002	CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1378457A Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras
11/06/2002	CN1378455A Use of diterpenoid triepoxides as anti-proliferative agent
11/06/2002	CN1378443A Cationic liposome delivery of taxanes to angiogenic blood vessels
11/06/2002	CN1377953A Medicinal wine for rheumatism
11/06/2002	CN1377693A Traditional Chinese medicine wine fore relaxing muscles and tendons and activating blood circulation, expelling wind and stopping pain, and relieving flatulence and relaxing the bowels
11/06/2002	CN1377683A Medicinal formula for curing sciatic nerve disease and protrusion of lumbar intervertebral disc
11/06/2002	CN1377682A Bone-setting pain stopping paste
11/06/2002	CN1377672A Rheumatic pain killing preparation
11/06/2002	CN1093852C 维生素ｄ酰胺衍生物 Amide derivatives of vitamin d
11/06/2002	CN1093767C Protein kinase C inhibitors
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476214 Inhibition of cytokine production
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476052 Isoindolines, method of use, and pharmaceutical compositions
11/05/2002	US6476046 Diazabicyclo[4.3.0]nonanes, and methods of use thereof
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476028 Compounds and methods
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002	US6476002 Treatment of chronic inflammatory diseases with CM101/GBS toxin
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475986 Uses of THANK, a TNF homologue that activates apoptosis
11/05/2002	US6475741 Antiinflammatory agents
11/05/2002	US6475524 Composition of matter
11/05/2002	US6475493 Controlled release pellet formulation
11/05/2002	US6475485 Two novel human cathepsin proteins
11/05/2002	US6475467 Medicinal aerosol formulations
11/05/2002	CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
11/05/2002	CA1341396C Cyclosporin crystal form, processes for its production pharmaceutical compositions containing it and its use
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086102A1 Lactic acid bacteria as agents for treating and preventing allergy
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002	WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085937A2 Inflammation-specific peptides and the uses thereof
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085925A2 Melanocortin receptor ligands
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085887A1 Phenyl- and pyridyl-piperidines with tnf activity
10/31/2002	WO2002085886A2 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002	WO2002085868A1 Benzoxazinone derivatives for use in the treatment of angiogenesis
10/31/2002	WO2002085863A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents
10/31/2002	WO2002085862A1 Imidazolidine derivatives as chemokine receptor modulators
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085839A1 Fused bicyclic or tricyclic amino acids
10/31/2002	WO2002085827A1 Extract from the pods of lupin seeds containing lupeol
10/31/2002	WO2002085414A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
10/31/2002	WO2002085410A2 Method for evaluating the efficacy of treatment with bacterial dna and bacterial cell walls
10/31/2002	WO2002085402A1 Methods and compositions for treating oral and eosophageal lesions
10/31/2002	WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002	WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002	WO2002085384A2 Lubricious coatings for substrates
10/31/2002	WO2002085376A2 A method for decreasing superoxide anion production and for the treatment of diseases associated with oxidative stress
10/31/2002	WO2002085361A1 Benzimidazolone compounds
10/31/2002	WO2002085359A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	WO2002085354A1 Spiroindene and spiroindane compounds
10/31/2002	WO2002085350A1 Prodigiosin composition for the treatment of rheumatic arthritis
10/31/2002	WO2002085347A1 Preventive/remedial agent for inflammatory disease in oral-cavity mucosa and the like

1 ... 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 ... 1272